name:-0.10171890258789
name:-0.10355091094971
name:-0.024890184402466
MEDIVIR AB Patent Filings

MEDIVIR AB

Patent Applications and Registrations

Patent applications and USPTO patent grants for MEDIVIR AB.The latest application filed is for "methods for treating liver cancers using an orally administered dioxolane nucleotide in combination with an anti-pd1 or anti-pdl1 monoclonal antibody".

Company Profile
24.124.100
  • MEDIVIR AB - Huddinge N/A SE
  • MEDIVIR AB - Stockholm N/A SE
  • Medivir AB - Besoksard Lungastigen SE
  • Medivir AB; - Huddinge SE
  • Medivir AB - SE SE
  • MEDIVIR AB - JANSSEN PRODUCTS, LP
  • Medivir AB - Lunastigen 7 Huddinge SE
  • Medivir AB - Lunastigen 17 Huddinge SE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Dioxolane analogues of uridine for the treatment of cancer
Grant 11,447,511 - Bethell , et al. September 20, 2
2022-09-20
SMAC mimetic
Grant 11,351,221 - Condon , et al. June 7, 2
2022-06-07
Protease inhibitors
Grant 11,312,693 - Oden , et al. April 26, 2
2022-04-26
Methods For Treating Liver Cancers Using An Orally Administered Dioxolane Nucleotide In Combination With An Anti-pd1 Or Anti-pdl1 Monoclonal Antibody
App 20220117983 - ALBERTELLA; Mark
2022-04-21
Base-Modified Cytidine Nucleotides for Leukemia Therapy
App 20210261584 - PINHO; Pedro ;   et al.
2021-08-26
Dioxolane Analogues Of Uridine For The Treatment Of Cancer
App 20210054008 - BETHELL; Richard ;   et al.
2021-02-25
Pharmaceutical Formulation for Histone Deacetylase Inhibitors
App 20210038555 - Chappell; Todd W. ;   et al.
2021-02-11
Protease Inhibitors
App 20210017140 - ODEN; Lourdes Salvador ;   et al.
2021-01-21
Cancer Treatment With (2,2-bishydroxymethyl) Methylenecyclopropane Nucleotides
App 20200399295 - KLASSON; Bjorn ;   et al.
2020-12-24
Dioxolane analogues of uridine for the treatment of cancer
Grant 10,822,360 - Bethell , et al. November 3, 2
2020-11-03
SMAC Mimetic
App 20200282002 - Condon; Stephen M. ;   et al.
2020-09-10
Dioxolane Analogues Of Uridine For The Treatment Of Cancer
App 20200239502 - BETHELL; Richard ;   et al.
2020-07-30
Protease inhibitors
Grant 10,723,709 - Oden , et al.
2020-07-28
Dioxolane analogues of uridine for the treatment of cancer
Grant 10,654,877 - Bethell , et al.
2020-05-19
SMAC mimetic
Grant 10,596,220 - Condon , et al.
2020-03-24
Therapeutic Applications Of Malt1 Inhibitors
App 20200009135 - ALBERTELLA; Mark ;   et al.
2020-01-09
Protease Inhibitors
App 20200010434 - ODEN; Lourdes Salvador ;   et al.
2020-01-09
Dioxolane Analogues Of Uridine For The Treatment Of Cancer
App 20190389890 - BETHELL; Richard ;   et al.
2019-12-26
SMAC Mimetic
App 20190255139 - Condon; Stephen M. ;   et al.
2019-08-22
Dioxolane analogues of uridine for the treatment of cancer
Grant 10,336,780 - Bethell , et al.
2019-07-02
Protease inhibitors
Grant 10,329,266 - Oden , et al.
2019-06-25
Pharmaceutical Formulation for Histone Deacetylase Inhibitors
App 20190175539 - Chappell; Todd W. ;   et al.
2019-06-13
SMAC mimetic
Grant 10,314,881 - Condon , et al.
2019-06-11
Pharmaceutical formulation for histone deacetylase inhibitors
Grant 10,258,595 - Chappell , et al.
2019-04-16
Dioxolane Analogues Of Uridine For The Treatment Of Cancer
App 20190100541 - BETHELL; Richard ;   et al.
2019-04-04
Hcv Polymerase Inhibitors
App 20190085010 - KALAYANOV; Genadiy ;   et al.
2019-03-21
HCV NS-3 serine protease inhibitors
Grant 10,172,846 - Rosenquist , et al. J
2019-01-08
Respiratory Syncytial Virus Inhibitors
App 20190002436 - AYESA; Susana ;   et al.
2019-01-03
Dioxolane analogues of cytidine for the treatment of cancer
Grant 10,144,750 - Bethell , et al. De
2018-12-04
Protease Inhibitors
App 20180327371 - ODEN; Lourdes Salvador ;   et al.
2018-11-15
Methods for the preparation of diastereomerically pure phosphoramidate prodrugs
Grant 10,118,941 - Pinho , et al. November 6, 2
2018-11-06
HCV polymerase inhibitors
Grant 10,106,571 - Kalayanov , et al. October 23, 2
2018-10-23
Hcv Polymerase Inhibitors
App 20180105549 - KALAYANOV; Genadiy ;   et al.
2018-04-19
Nucleotide Phosphoramidate Formulation
App 20180036330 - ANDERSSON; Mattias
2018-02-08
Macrocyclic inhibitors of hepatitis C virus
Grant 9,856,265 - Simmen , et al. January 2, 2
2018-01-02
HCV polymerase inhibitors
Grant 9,828,408 - Kalayanov , et al. November 28, 2
2017-11-28
Protease Inhibitors
App 20170334867 - ODEN; Lourdes Salvador ;   et al.
2017-11-23
Methods For The Preparation Of Diastereomerically Pure Phosphoramidate Prodrugs
App 20170275322 - PINHO; Pedro ;   et al.
2017-09-28
Dioxolane Analogues Of Uridine For The Treatment Of Cancer
App 20170267705 - BETHEL; Richard ;   et al.
2017-09-21
Macrocyclic Inhibitors Of Hepatitis C Virus
App 20170226111 - Simmen; Kenneth Alan ;   et al.
2017-08-10
Respiratory syncytial virus inhibitors
Grant 9,708,332 - Sturino , et al. July 18, 2
2017-07-18
Hcv Ns-3 Serine Protease Inhibitors
App 20170196849 - Rosenquist; Asa ;   et al.
2017-07-13
Protease Inhibitors
App 20170166538 - ODEN; Lourdes Salvador ;   et al.
2017-06-15
Form 2 crystalline polymorph of a salt of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-B]pyrrole-4-carbonyl)-3-methyl-b- utyl]-4-[5-fluoro-2-(4-methyl-piperazinyl) thiazol-4-yl]-benzamide useful as cysteine protease inhibitor
Grant 9,650,388 - Grabowska , et al. May 16, 2
2017-05-16
Treatment Of Chagas Disease
App 20170114029 - KAHNBERG; Pia ;   et al.
2017-04-27
Hcv Polymerase Inhibitors
App 20170107244 - KALAYANOV; Genadiy ;   et al.
2017-04-20
Macrocyclic inhibitors of hepatitis C virus
Grant 9,623,022 - Simmen , et al. April 18, 2
2017-04-18
HCV polymerase inhibitors
Grant 9,540,411 - Kalayanov , et al. January 10, 2
2017-01-10
Hcv Polymerase Inhibitors
App 20160340380 - KALAYANOV; Genadiy ;   et al.
2016-11-24
HCV polymerase inhibitors
Grant 9,481,703 - Kalayanov , et al. November 1, 2
2016-11-01
Hcv Polymerase Inhibitors
App 20160271160 - KALAYANOV; Genadiy ;   et al.
2016-09-22
Respiratory Syncytial Virus Inhibitors
App 20160272646 - STURINO; Claudio ;   et al.
2016-09-22
Protease inhibitors
Grant 9,428,517 - Oden , et al. August 30, 2
2016-08-30
Macrocyclic Inhibitors Of Hepatitis C Virus
App 20160235737 - Simmen; Kenneth Alan ;   et al.
2016-08-18
Form 2 Crystalline Polymorph Of A Salt Of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-b]pyrrole-4-carbonyl)-3-methyl-b- Utyl]-4-[5-fluoro-2-(4-methyl-piperazinyl)thiazol-4-yl]-benzamide Useful As Cysteine Protease Inhibitor
App 20160194334 - GRABOWSKA; Urszula ;   et al.
2016-07-07
Macrocyclic inhibitors of hepatitis C virus
Grant 9,353,103 - Simmen , et al. May 31, 2
2016-05-31
Protease Inhibitors
App 20160068539 - ODEN; Lourdes Salvador ;   et al.
2016-03-10
Protease inhibitors
Grant 9,200,006 - Oden , et al. December 1, 2
2015-12-01
Macrocyclic Inhibitors Of Hepatitis C Virus
App 20150218153 - Simmen; Kenneth Alan ;   et al.
2015-08-06
Hcv Polymerase Inhibitors
App 20150175648 - KALAYANOV; Genadiy ;   et al.
2015-06-25
Macrocyclic inhibitors of hepatitis C virus
Grant 9,040,562 - Simmen , et al. May 26, 2
2015-05-26
Macrocyclic inhibitors of hepatitis C virus
Grant 9,023,808 - Simmen , et al. May 5, 2
2015-05-05
Uracyl spirooxetane nucleoside phosphoramidates
Grant 9,012,428 - Jonckers , et al. April 21, 2
2015-04-21
Uracyl spirooxetane nucleoside phosphoramidates
Grant 9,006,209 - Jonckers , et al. April 14, 2
2015-04-14
Pyrimidine substituted macrocyclic HCV inhibitors
Grant 8,937,080 - Raboisson , et al. January 20, 2
2015-01-20
Uracyl spirooxetane nucleosides
Grant 8,933,052 - Jonckers , et al. January 13, 2
2015-01-13
Macrocyclic Inhibitors Of Hepatitis C Virus
App 20140255347 - Simmen; Kenneth Alan ;   et al.
2014-09-11
Protease Inhibitors
App 20140221654 - ODEN; Lourdes Salvador ;   et al.
2014-08-07
Macrocyclic inhibitors of hepatitis C virus
Grant 8,754,105 - Simmen , et al. June 17, 2
2014-06-17
Macrocyclic inhibitors of hepatitis C virus
Grant 8,754,106 - Simmen , et al. June 17, 2
2014-06-17
Macrocyclic inhibitors of hepatitis C virus
Grant 8,741,926 - Simmen , et al. June 3, 2
2014-06-03
Protease inhibitors
Grant 8,735,395 - Oden , et al. May 27, 2
2014-05-27
Hcv Polymerase Inhibitors
App 20140066398 - ENEROTH; Anders ;   et al.
2014-03-06
Phosphoramidate derivatives of nucleosides
Grant 8,552,021 - Jonckers , et al. October 8, 2
2013-10-08
Protease Inhibitors
App 20130231349 - ODEN; Lourdes Salvador ;   et al.
2013-09-05
Combination Of Alovudine And Zidovudine In A Molar Ratio Of 1:100 To 1:350
App 20130217646 - ZHANG; Hong ;   et al.
2013-08-22
Macrocyclic Inhibitors Of Hepatitis C Virus
App 20130217725 - Simmen; Kenneth Alan ;   et al.
2013-08-22
Uracyl Spirooxetane Nucleosides
App 20130217648 - Jonckers; Tim Hugo Maria ;   et al.
2013-08-22
Uracyl spirooxetane nucleosides
Grant 8,481,510 - Jonckers , et al. July 9, 2
2013-07-09
Cysteine protease inhibitors
Grant 8,466,158 - Nilsson , et al. June 18, 2
2013-06-18
HCV Polymerase Inhibitors
App 20130143835 - ENEROTH; Anders ;   et al.
2013-06-06
Cyclopropyl polymerase inhibitors
Grant 8,431,588 - Jonckers , et al. April 30, 2
2013-04-30
Protease inhibitors
Grant 8,426,421 - Oden , et al. April 23, 2
2013-04-23
Macrocyclic Inhibitors Of Hepatitis C Virus
App 20130089520 - Simmen; Kenneth Alan ;   et al.
2013-04-11
Uracyl cyclopropyl nucleotides
Grant 8,399,429 - Jonckers , et al. March 19, 2
2013-03-19
HCV inhibiting macrocyclic phenylcarbamates
Grant 8,383,584 - Antonov , et al. February 26, 2
2013-02-26
Combination of a Macrocyclic Inhibitor of HCV, A Non-Nucleoside and a Nucleoside
App 20130028865 - Lin; Tse-I ;   et al.
2013-01-31
Macrocylic inhibitors of hepatitis C virus
Grant 8,349,869 - Simmen , et al. January 8, 2
2013-01-08
(2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors
Grant 8,338,471 - Wallberg , et al. December 25, 2
2012-12-25
Protease Inhibitors
App 20120289519 - ODEN; Lourdes Salvador ;   et al.
2012-11-15
Phosphoramidate Derivatives of Nucleosides
App 20120225839 - Jonckers; Tim Hugo Maria ;   et al.
2012-09-06
Cysteine Protease Inhibitors
App 20120220602 - Nilsson; Magnus ;   et al.
2012-08-30
Protease inhibitors
Grant 8,242,119 - Oden , et al. August 14, 2
2012-08-14
Macrocyclic inhibitors of hepatitis C virus
Grant 8,227,407 - Simmen , et al. July 24, 2
2012-07-24
Cysteine protease inhibitors
Grant 8,198,283 - Nilsson , et al. June 12, 2
2012-06-12
Acyclic Nucleoside Derivatives
App 20120123119 - ENGELHARDT; Per ;   et al.
2012-05-17
Combination Of Alovudine And Zidovudine In A Molar Ratio Of 1:100 To 1:350
App 20120115807 - ZHANG; Hong ;   et al.
2012-05-10
Antiviral nucleosides
Grant 8,158,779 - Johansson , et al. April 17, 2
2012-04-17
1-[2', 3' -dideoxy-3' C- (hydroxymethyl)--beta-D-erythro-pentofuranosyl] cytosine derivatives as HIV inhibitors
Grant 8,143,396 - Zhou , et al. March 27, 2
2012-03-27
Acyclic nucleoside derivatives
Grant 8,124,609 - Engelhardt , et al. February 28, 2
2012-02-28
(2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides As Metalloproteinase Inhibitors
App 20120015994 - WALLBERG; Hans ;   et al.
2012-01-19
(2,5-dioxoimidazolidin-1-yl)-N-hydroxy-acetamides as metalloproteinase inhibitors
Grant 8,022,092 - Wallberg , et al. September 20, 2
2011-09-20
Dutpase inhibitors
Grant 8,017,620 - Gilbert , et al. September 13, 2
2011-09-13
Macrocyclic inhibitors of hepatitis C virus
Grant 8,012,939 - Simmen , et al. September 6, 2
2011-09-06
Macrocyclic inhibitors of hepatitis C virus
Grant 8,008,251 - Simmen , et al. August 30, 2
2011-08-30
Antiviral Nucleosides
App 20110172410 - JOHANSSON; Nils-Gunnar ;   et al.
2011-07-14
Cysteine Protease Inhibitors
App 20110112089 - NILSSON; Magnus ;   et al.
2011-05-12
1-[2', 3' -dideoxy-3' C- (hydroxymethyl) - Beta-d-erythro-pentofuranosyl] Cytosine Derivatives As Hiv Inhibitors
App 20110112294 - ZHOU; Xiao-Xiong ;   et al.
2011-05-12
Cysteine Protease Inhibitors
App 20110105524 - NILSSON; Magnus ;   et al.
2011-05-05
Antiviral nucleosides
Grant 7,935,681 - Johansson , et al. May 3, 2
2011-05-03
Cysteine protease inhibitors
Grant 7,915,300 - Nilsson , et al. March 29, 2
2011-03-29
Non-nucleotide reverse transcriptase inhibitors
Grant 7,915,295 - Sund , et al. March 29, 2
2011-03-29
Cysteine protease inhibitors
Grant 7,893,067 - Nilsson , et al. February 22, 2
2011-02-22
Protease Inhibitors
App 20110039862 - Oden; Lourdes Salvadore ;   et al.
2011-02-17
1-[2',3' -dideoxy-3' C-(hydroxymethyl)--beta-D-erythro-pentofuranosyl] cytosine derivatives as HIV
Grant 7,888,367 - Zhou , et al. February 15, 2
2011-02-15
Dutpase Inhibitors
App 20110021459 - GILBERT; Ian ;   et al.
2011-01-27
Antiviral Nucleosides
App 20110015148 - Johansson; Nil-Gunnar ;   et al.
2011-01-20
Compounds useful in the treatment of HIV
Grant 7,829,548 - Zhou , et al. November 9, 2
2010-11-09
Antiviral nucleosides
Grant 7,825,239 - Kalyanov , et al. November 2, 2
2010-11-02
Antiviral methods employing double esters of 2', 3'-dideoxy-3'-fluoroguanosine
Grant 7,825,238 - Zhou , et al. November 2, 2
2010-11-02
HIV protease inhibitors
Grant 7,807,677 - Ekegren , et al. October 5, 2
2010-10-05
DUTPase inhibitors
Grant 7,795,270 - Gilbert , et al. September 14, 2
2010-09-14
Hcv Ns-3 Serine Protease Inhibitors
App 20100166706 - Rosenquist; Asa ;   et al.
2010-07-01
Antiviral Nucleosides
App 20100130735 - Kalyanov; Genadiy ;   et al.
2010-05-27
Macrocyclic inhibitors of hepatitis C virus
Grant 7,700,552 - Wahling , et al. April 20, 2
2010-04-20
Dutpase Inhibitors
App 20100075924 - Gilbert; Ian ;   et al.
2010-03-25
HCV NS-3 serine protease inhibitors
Grant 7,671,032 - Rosenquist , et al. March 2, 2
2010-03-02
Antiviral nucleosides
Grant 7,666,856 - Johansson , et al. February 23, 2
2010-02-23
Hcv Inhibiting Macrocyclic Phenylcarbamates
App 20100041728 - Antonov; Dmitry ;   et al.
2010-02-18
HCV NS-3 Serine Protease Inhibitors
App 20100003216 - Rosenquist; Asa ;   et al.
2010-01-07
Macrocyclic inhibitors of hepatitis c virus
App 20090281140 - Simmen; Kenneth Alan ;   et al.
2009-11-12
Antiviral Formulation
App 20090270429 - LARSON; Torbjorn
2009-10-29
HCV NS-3 serine protease inhibitors
Grant 7,608,590 - Rosenquist , et al. October 27, 2
2009-10-27
Dutpase Inhibitors
Grant 7,601,702 - Gilbert , et al. October 13, 2
2009-10-13
(2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides As Metalloproteinase Inhibitors
App 20090215846 - Wallberg; Hans ;   et al.
2009-08-27
Non-nucleoside reverse transcriptase inhibitors
Grant 7,517,992 - Antonov , et al. April 14, 2
2009-04-14
Acyclic Nucleoside Derivatives
App 20090076041 - ENGELHARDT; Per ;   et al.
2009-03-19
Macrocyclic Inhibitors of Hepatitis C Virus
App 20090023758 - Wahling; Horst ;   et al.
2009-01-22
Acyclic nucleoside derivatives
Grant 7,432,274 - Engelhardt , et al. October 7, 2
2008-10-07
Non-nucleoside reverse transcriptase inhibitors
Grant 7,405,310 - Lindstrom , et al. July 29, 2
2008-07-29
Compounds Useful in the Treatment of Hiv
App 20080176817 - Zhou; Xiao-Xiong ;   et al.
2008-07-24
Non-Nucleotide Reverse Transcriptase Inhibitors
App 20080070951 - Sund; Christian ;   et al.
2008-03-20
Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
Grant 7,223,387 - Lekare May 29, 2
2007-05-29
Synthesis of acyclic nucleoside derivatives
Grant 7,189,849 - Leanna , et al. March 13, 2
2007-03-13
Antivirals
Grant 7,148,243 - Sahlberg , et al. December 12, 2
2006-12-12
Pharmaceutical combination
Grant RE39,264 - Harmenberg , et al. September 5, 2
2006-09-05
Non-nucleoside reverse transcriptase inhibitors
App 20060167055 - Antonov; Dmitry ;   et al.
2006-07-27
Antiviral methods employing double esters of 2', 3'-dideoxy-3'-fluoroguanosine
Grant 7,071,173 - Zhou , et al. July 4, 2
2006-07-04
Antiviral methods employing double esters of 2', 3'-dideoxy-3'-fluoroguanosine
App 20060122383 - Zhou; Xiao-Xiong ;   et al.
2006-06-08
Synergistic interaction of abacavir and alovudine
App 20060084627 - Mardh; Goran
2006-04-20
Antiviral Methods Employing Double Esters Of 2', 3'-dideoxy-3'-fluoroguanosine
App 20060058259 - Zhou; Xiao-Xiong ;   et al.
2006-03-16
Treatment of viral infections using prodrugs of 2',3-dideoxy,3'-fluoroguanosine
Grant 6,974,802 - Zhou , et al. December 13, 2
2005-12-13
Synthesis of acyclic nucleoside derivatives
App 20050250795 - Leanna, M. Robert ;   et al.
2005-11-10
Non-nucleoside reverse transcriptase inhibitors
App 20050240035 - Lindstrom, Stefan ;   et al.
2005-10-27
Intermediate compounds of non-nucleoside reverse transcriptase inhibitors
Grant 6,894,177 - Lindstrom , et al. May 17, 2
2005-05-17
Synthesis of acyclic nucleoside derivatives
Grant 6,878,844 - Leanna , et al. April 12, 2
2005-04-12
Cysteine protease inhibitors
App 20050070598 - Quibell, Martin ;   et al.
2005-03-31
Synthesis of acyclic nucleoside derivatives
App 20040248910 - Leanna, M. Robert ;   et al.
2004-12-09
Cysteine protease inhibitors
App 20040229915 - Quibell, Martin ;   et al.
2004-11-18
Acyclic nucleoside derivatives
App 20040132749 - Engelhardt, Per ;   et al.
2004-07-08
Compounds and methods for inhibition of HIV and related viruses
App 20040116418 - Lind, Peter Thomas ;   et al.
2004-06-17
Non-nucleoside reverse transcriptase inhibitors
Grant 6,716,850 - Lindstrom , et al. April 6, 2
2004-04-06
Acyclic nucleoside derivatives
Grant 6,703,394 - Engelhardt , et al. March 9, 2
2004-03-09
Synthesis of acyclic nucleoside derivatives
App 20040024214 - Leanna, M. Robert ;   et al.
2004-02-05
Non-nucleoside reverse transcriptase inhibitors
App 20030187266 - Lindstrom, Stefan ;   et al.
2003-10-02
Prodrugs
App 20030186924 - Zhou, Xiao-Xiong ;   et al.
2003-10-02
Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
App 20030171344 - Lekare, Gunilla
2003-09-11
Synthesis of acyclic nucleoside derivatives
Grant 6,613,936 - Leanna , et al. September 2, 2
2003-09-02
Non-nucleoside reverse transcriptase inhibitors
Grant 6,610,714 - Sahlberg , et al. August 26, 2
2003-08-26
Antivirals
App 20030119881 - Salhberg, Christer ;   et al.
2003-06-26
Non-nucleoside Reverse Transcriptase Inhibitors
App 20030092743 - Sahlberg, Christer ;   et al.
2003-05-15
Non-nucleoside reverse transcriptase inhibitors
App 20030069224 - Lindstrom, Stefan ;   et al.
2003-04-10
Acyclic nucleoside derivatives
App 20020188125 - Engelhardt, Per ;   et al.
2002-12-12
Antiviral protease inhibitors
Grant 6,489,364 - Classon , et al. December 3, 2
2002-12-03
Compounds and methods for inhibition of HIV and related viruses
App 20020132794 - Lind, Peter Thomas ;   et al.
2002-09-19
Pharmaceutical combination
Grant 6,337,324 - Harmenberg , et al. January 8, 2
2002-01-08
Antiviral protease inhibitors
App 20010044547 - Classon, Bjorn ;   et al.
2001-11-22
Antiviral protease inhibitors
Grant 6,291,687 - Classon , et al. September 18, 2
2001-09-18
Acyclic nucleoside derivatives
Grant 5,869,493 - Engelhardt , et al. February 9, 1
1999-02-09
N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection
Grant 5,849,769 - Lind , et al. December 15, 1
1998-12-15
Method for inhibition of HIV related viruses
Grant 5,593,993 - Morin, Jr. , et al. January 14, 1
1997-01-14
1-(3'-fluoro-2',3'-dideoxy-.beta.-D-ribofuranosyl)-5-substituted pyrimidine nucleosides
Grant 5,506,215 - Johansson , et al. April 9, 1
1996-04-09
Synthesis of furanosyl compounds useful as intermediates in preparation of nucleoside analogues
Grant 5,473,063 - Classon , et al. December 5, 1
1995-12-05
Anti-retroviral activity of 2',3'-dideoxy-3'-fluoronucleosides
Grant 5,446,029 - Eriksson , et al. August 29, 1
1995-08-29
Pyrimidine intermediates
Grant 5,440,040 - Gronowitz August 8, 1
1995-08-08
Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds
Grant 5,215,970 - Datema , et al. June 1, 1
1993-06-01
Antiviral pharmaceutical composition comprising 5-substituted pyrimidine nucleosides
Grant 5,215,971 - Datema , et al. June 1, 1
1993-06-01
Company Registrations
SEC0001573866Medivir AB/ADR

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed